Two Sigma Advisers’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
Two Sigma Advisers's HCAT Position: Q1 2026 in Review
Two Sigma Advisers sold out of Health Catalyst (HCAT) in Q1 2026, closing a stake of 31,100 shares — an estimated $74.3K sold.
Two Sigma Advisers first reported a position in HCAT in Q1 2021 and held it in 17 quarters. The position peaked at $5.13M in Q2 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- Two Sigma Advisers reported no remaining Health Catalyst position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 31,100 Health Catalyst shares in Q1 2026, an estimated $74.3K.
- Two Sigma Advisers first reported a position in Health Catalyst in Q1 2021 and held it in 17 quarters.
- Two Sigma Advisers's Health Catalyst position peaked at $5.13M in Q2 2023.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.